Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers
The majority of human breast cancer is estrogen receptor alpha (ER) positive. While anti-estrogens/aromatase inhibitors are initially effective, resistance to these drugs commonly develops. Therapy-resistant tumors often retain ER signaling, via interaction with critical oncogenic coregulator protei...
-д хадгалсан:
| Үндсэн зохиолчид: | , , , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
eLife Sciences Publications Ltd
2017-08-01
|
| Цуврал: | eLife |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://elifesciences.org/articles/26857 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|
